Follow PharmaTimes: News RSS, filter it, and define how you want to receive the news (via Email, RSS, Telegram, WhatsApp etc.) https://follow.it/pharmatimes-news-rss Sat, 24 Sep 2022 22:32:51 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoiYSiDv21Hz84HQhe4ZUzd Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance]]> Fri, 23 Sep 2022 12:42:53 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoiYSiDv21Hz84HQhe4ZUzd https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoiYSiDv21Hz-m6srrLMsqK 1,500 people set to receive new skin cancer treatment that reduces the risk of it returning]]> Fri, 23 Sep 2022 12:41:09 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoiYSiDv21Hz-m6srrLMsqK https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqTuh_3Mgk5aGw5Ur-z5Bww Data shows participants achieved greater treatment satisfaction when switching to icodec]]> Thu, 22 Sep 2022 13:13:47 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqTuh_3Mgk5aGw5Ur-z5Bww https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr_npRzUECFHSVCAQLB0bf5 Company presents new pain data on the anti-inflammatory effects of its TrkA-NAM]]> Thu, 22 Sep 2022 13:04:32 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMr_npRzUECFHSVCAQLB0bf5 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrZmFjAXmVumwX50KYzL9tX A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial]]> Wed, 21 Sep 2022 12:21:56 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrZmFjAXmVumwX50KYzL9tX https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqNYV2KMfQzugpx5_w21kha Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations]]> Wed, 21 Sep 2022 12:18:07 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqNYV2KMfQzugpx5_w21kha https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpg40w0-KqWxJu9CxXrVx4c Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis]]> Tue, 20 Sep 2022 13:55:24 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpg40w0-KqWxJu9CxXrVx4c https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpg40w0-KqWxEGb1Jh49AJn The two biotech leaders have embarked on a research project to streamline manufacturing]]> Tue, 20 Sep 2022 13:53:19 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpg40w0-KqWxEGb1Jh49AJn https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-Eoy9CZgXDJO Therapy has been developed for the prevention of disease in infants]]> Fri, 16 Sep 2022 12:35:37 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-Eoy9CZgXDJO https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-O9WSSr4-0sP Celebrating excellence in clinical research for over decades.]]> Fri, 16 Sep 2022 12:30:19 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-O9WSSr4-0sP https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-HHnycKeoCpf Exploratory central nervous system analysis shows that ACD856 increases activity in brain]]> Fri, 16 Sep 2022 12:26:18 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMpAM9VFRkdp-HHnycKeoCpf https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMriDEAGdeUWzIeLGixeGJZp European wide research infrastructures, oncology experts and patient associations link up to combat cancer]]> Thu, 15 Sep 2022 11:24:13 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMriDEAGdeUWzIeLGixeGJZp https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMriDEAGdeUWzBKeetMRuZbW The PRO-C6 biomarker assay has been transferred to Roche Diagnostics for further analysis]]> Thu, 15 Sep 2022 11:21:01 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMriDEAGdeUWzBKeetMRuZbW https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoprRKKUYQY_4fjc6hd5eWF Study reveals first genetic links in chronic fatigue syndrome, paving the way for new drugs]]> Wed, 14 Sep 2022 14:00:13 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoprRKKUYQY_4fjc6hd5eWF https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoprRKKUYQY_yVCAQLB0bf5 Therapy is for the treatment of spasticity due to multiple sclerosis]]> Wed, 14 Sep 2022 13:57:06 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoprRKKUYQY_yVCAQLB0bf5 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqwL279UgxRsYMOI2eu70Rg Modelling indicates a 307% increase in cases identified between 2020 and 2021]]> Tue, 13 Sep 2022 13:28:51 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqwL279UgxRsYMOI2eu70Rg https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFQthSj5aRa0oy9CZgXDJO Up-LIFT research achieves primary endpoint with improvement in arm and hand function]]> Tue, 13 Sep 2022 13:25:49 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoFQthSj5aRa0oy9CZgXDJO https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrF36uHiZEYCYeLGixeGJZp Collaboration will involve sophisticated screening for cardiac-based drug discovery]]> Mon, 12 Sep 2022 13:33:10 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrF36uHiZEYCYeLGixeGJZp https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrtD2OU-od2fIfjc6hd5eWF Tislelizumab shows favourable safety profile compared to sorafenib among liver cancer patients]]> Mon, 12 Sep 2022 13:18:43 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrtD2OU-od2fIfjc6hd5eWF https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoivXHFSMiA45u9CxXrVx4c Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer]]> Fri, 09 Sep 2022 13:56:25 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoivXHFSMiA45u9CxXrVx4c